RIGL Rigel Pharmaceuticals
- 1.130
- +0.050+4.63%
- 1.100
- -0.030-2.65%
Rigel Pharmaceuticals News
Rigel Pharmaceuticals Analyst Ratings
Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $4
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Rigel Pharmaceuticals Analyst Ratings
Rigel Pharmaceuticals Analyst Ratings
Holding Steady: A Detailed Analysis of Rigel Pharmaceuticals' Performance and Prospects
Rigel Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
Piper Sandler Assumes Rigel Pharmaceuticals at Neutral, Announces Price Target of $2
HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target
BMO Capital Maintains Outperform on Rigel Pharmaceuticals, Lowers Price Target to $3
HC Wainwright Adjusts Rigel Pharmaceuticals' Price Target to $15 From $7, Keeps Buy Rating
Rigel Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Rigel Pharmaceuticals Price Target Raised to $15.00/Share From $7.00 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $15
Rigel Pharmaceuticals Is Maintained at Neutral by Piper Sandler
Rigel Pharmaceuticals Price Target Raised to $2.00/Share From $1.00 by Piper Sandler
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $2
Analysis
Price Target
No Data
